Saad Al‐Ismail

646 total citations
29 papers, 355 citations indexed

About

Saad Al‐Ismail is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Saad Al‐Ismail has authored 29 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Saad Al‐Ismail's work include Cancer survivorship and care (7 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Palliative Care and End-of-Life Issues (5 papers). Saad Al‐Ismail is often cited by papers focused on Cancer survivorship and care (7 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Palliative Care and End-of-Life Issues (5 papers). Saad Al‐Ismail collaborates with scholars based in United Kingdom, Italy and Russia. Saad Al‐Ismail's co-authors include J. A. Whittaker, John Gough, Roger Munro, Kirk Morris, A. J. Beddall, Stewart McConnell, Adele K. Fielding, Jonathan Kell, Tatyana Ionova and Esther N. Oliva and has published in prestigious journals such as Blood, British Journal of Cancer and British Journal of Haematology.

In The Last Decade

Saad Al‐Ismail

29 papers receiving 337 citations

Peers

Saad Al‐Ismail
Lale Olcay Türkiye
Marie‐Pierre Desrosiers United States
S. E. Kinsey United Kingdom
Saïd Benchekroun Morocco
Moaath K. Mustafa Ali United States
Namita Tundia United States
Ghaleb Elyamany Saudi Arabia
Gilberto Perez Cardoso Brazil
Luca Cupelli Italy
Ertuğrul Eğilmez Türkiye
Lale Olcay Türkiye
Saad Al‐Ismail
Citations per year, relative to Saad Al‐Ismail Saad Al‐Ismail (= 1×) peers Lale Olcay

Countries citing papers authored by Saad Al‐Ismail

Since Specialization
Citations

This map shows the geographic impact of Saad Al‐Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saad Al‐Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saad Al‐Ismail more than expected).

Fields of papers citing papers by Saad Al‐Ismail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saad Al‐Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saad Al‐Ismail. The network helps show where Saad Al‐Ismail may publish in the future.

Co-authorship network of co-authors of Saad Al‐Ismail

This figure shows the co-authorship network connecting the top 25 collaborators of Saad Al‐Ismail. A scholar is included among the top collaborators of Saad Al‐Ismail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saad Al‐Ismail. Saad Al‐Ismail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliva, Esther N., Tatyana Ionova, Jonathan Kell, et al.. (2020). Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study. Frontiers in Pharmacology. 11. 1308–1308. 12 indexed citations
2.
Oliva, Esther N., Tatyana Ionova, Jonathan Kell, et al.. (2020). Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO. Frontiers in Pharmacology. 11. 571066–571066. 5 indexed citations
3.
Oliva, Esther N., Tatyana Ionova, Jonathan Kell, et al.. (2020). Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity. Frontiers in Pharmacology. 11. 209–209. 13 indexed citations
4.
Oliva, Esther N., Tatyana Ionova, Jonathan Kell, et al.. (2020). Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study. Therapeutic Advances in Hematology. 11. 154246778–154246778. 20 indexed citations
5.
Oliva, Esther N., Tatyana Ionova, Jonathan Kell, et al.. (2019). Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study. Journal of Comparative Effectiveness Research. 8(7). 523–533. 16 indexed citations
6.
Muthukrishnan, Arvind, Saad Al‐Ismail, Gianfilippo Bertelli, & Paul Browne. (2017). MRONJ risk reduction pathway - 360 degree survey. BDJ. 222(5). 386–390. 4 indexed citations
7.
Salek, Sam, Adele K. Fielding, Jonathan Kell, et al.. (2016). Development of a Novel Patient-Reported Outcome Measure in Haematological Malignancy for Use in Routine Clinical Practice: Item Generation. Blood. 128(22). 5985–5985. 8 indexed citations
8.
Al‐Ismail, Saad, et al.. (2008). Two-centre evaluation of the Abbott CD3500 blood counter. Clinical & Laboratory Haematology. 17(1). 11–21. 4 indexed citations
9.
Al‐Ismail, Saad, et al.. (2008). Immunophenotyping of normal lymphocytes. Clinical & Laboratory Haematology. 16(1). 21–32. 4 indexed citations
10.
Munro, Roger, Rhys Williams, Bruce Davies, et al.. (2008). Fibrinogen Reference Range in Adolescents. Blood. 112(11). 4091–4091. 1 indexed citations
11.
Al‐Ismail, Saad, et al.. (2007). Robust, routine haematology reference ranges for healthy adults. International Journal of Laboratory Hematology. 29(4). 279–283. 53 indexed citations
12.
Williams, John G, et al.. (2004). Clinical guidelines online: do they improve compliance?. Postgraduate Medical Journal. 80(945). 415–419. 18 indexed citations
13.
Al‐Ismail, Saad, et al.. (2004). Prevalence of the Sickle Cell Gene in Yemen: A Pilot Study. Hemoglobin. 28(4). 305–315. 15 indexed citations
14.
Al‐Ismail, Saad, et al.. (1999). POSTINFECTION PURPURA FULMINANS IN A PATIENT HETEROZYGOUS FOR PROTHROMBIN G20210A AND ACQUIRED PROTEIN S RESISTANCE. Pediatric Hematology and Oncology. 16(6). 561–564. 13 indexed citations
15.
Wynn, Robert, Simon Dixon, Saad Al‐Ismail, et al.. (1995). Flow cytometric determination of pre‐transfusion red cell volume in fetuses and neonates requiring transfusion based on RhD+ dilution by transfused D‐ red cells. British Journal of Haematology. 89(3). 620–622. 9 indexed citations
16.
Macdonald, D., et al.. (1995). New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia. Blood. 85(5). 1377–1380. 36 indexed citations
17.
Al‐Ismail, Saad, et al.. (1987). Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma. European Journal of Cancer and Clinical Oncology. 23(9). 1379–1384. 21 indexed citations
18.
Whittaker, J. A. & Saad Al‐Ismail. (1984). Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukaemia.. BMJ. 288(6413). 283.2–284. 18 indexed citations
19.
Al‐Ismail, Saad, Diane Parry, C. U. MOISEY, & A. L. Bloom. (1979). Factor VIII Inhibitor and Bronchogenic Carcinoma. Thrombosis and Haemostasis. 41(2). 291–295. 11 indexed citations
20.
Al‐Ismail, Saad, Diane Parry, & J. A. Whittaker. (1977). Anthracycline cardiotoxicity and acute myelogenous leukaemia.. BMJ. 1(6064). 815.1–815. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lale Olcay Breakdown of academic impact, for papers by Marie‐Pierre Desrosiers Breakdown of academic impact, for papers by S. E. Kinsey Breakdown of academic impact, for papers by Saïd Benchekroun Breakdown of academic impact, for papers by Moaath K. Mustafa Ali Breakdown of academic impact, for papers by Namita Tundia Breakdown of academic impact, for papers by Ghaleb Elyamany Breakdown of academic impact, for papers by Gilberto Perez Cardoso Breakdown of academic impact, for papers by Luca Cupelli Breakdown of academic impact, for papers by Ertuğrul Eğilmez
Rankless by CCL
2026